Literature DB >> 16741619

Possible association of vigorous hepatitis B virus replication with the development of fulminant hepatitis.

Kazuaki Inoue1, Osamu Ogawa, Masaya Yamada, Tsunamasa Watanabe, Hiroaki Okamoto, Makoto Yoshiba.   

Abstract

A 49 year-old man was referred to our hospital for fear of developing fulminant hepatic failure. There had been an outbreak of fulminant hepatitis B in a dialysis clinic in the western part of Honshu, Japan, that resulted in four deaths among six patients. After the sixth patient contracted severe hepatitis, all patients in the unit were screened biweekly for hepatitis B surface antigen (HBsAg) to detect newly infected patients as soon as possible. Our patient was the seventh victim, and on the day he gave a positive result for HBsAg, his hepatitis B virus (HBV) DNA level had reached 1.1 x 10(11) copies/ml as assessed by real time polymerase chain reaction. Sequence analysis of the causal HBV revealed the presence of a mutation in the precore region (nt 1896), two mutations in the core promoter (nt 1762 and nt 1764), and some minor mutations in the P gene that were restricted to the upstream region. These mutations are indicative of a virus with a high replicative rate that cannot secrete HBeAg. Taken together, these findings indicate that it is very likely that the replicative ability of the causal virus was as vigorous as that of HBV in hepatitis B e antigen-positive asymptomatic carriers with markedly high viral titers. The present case report provides clinical evidence of a possible association between the rapid spread of highly replicative HBV before host immunological recognition and the development of fulminant hepatitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741619     DOI: 10.1007/s00535-006-1785-2

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  17 in total

1.  Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen.

Authors:  Y Kosaka; K Takase; M Kojima; M Shimizu; K Inoue; M Yoshiba; S Tanaka; Y Akahane; H Okamoto; F Tsuda
Journal:  Gastroenterology       Date:  1991-04       Impact factor: 22.682

2.  Clinical and molecular virological differences between fulminant hepatic failures following acute and chronic infection with hepatitis B virus.

Authors:  K Inoue; M Yoshiba; K Sekiyama; H Okamoto; M Mayumi
Journal:  J Med Virol       Date:  1998-05       Impact factor: 2.327

3.  Search for hepatitis B virus DNA in sera from patients with acute type B or non-A, non-B hepatitis.

Authors:  N C Tassopoulos; G J Papaevangelou; A Roumeliotou-Karayannis; J R Ticehurst; S M Feinstone; R H Purcell
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

4.  Quantitation of hepatitis B virus genomic DNA by real-time detection PCR.

Authors:  A Abe; K Inoue; T Tanaka; J Kato; N Kajiyama; R Kawaguchi; S Tanaka; M Yoshiba; M Kohara
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

5.  Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance.

Authors:  C G Trepo; D Robert; J Motin; D Trepo; M Sepetjian; A M Prince
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

6.  Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B.

Authors:  I L Woolf; N El Sheikh; H Cullens; W M Lee; A L Eddleston; R Williams; A J Zuckerman
Journal:  Br Med J       Date:  1976-09-18

7.  Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis.

Authors:  S Sato; K Suzuki; Y Akahane; K Akamatsu; K Akiyama; K Yunomura; F Tsuda; T Tanaka; H Okamoto; Y Miyakawa; M Mayumi
Journal:  Ann Intern Med       Date:  1995-02-15       Impact factor: 25.391

8.  Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.

Authors:  F Bonino; F Rosina; M Rizzetto; R Rizzi; E Chiaberge; R Tardanico; F Callea; G Verme
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

9.  Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease.

Authors:  M Horikita; S Itoh; K Yamamoto; T Shibayama; F Tsuda; H Okamoto
Journal:  J Med Virol       Date:  1994-09       Impact factor: 2.327

10.  Kinetics of acute hepatitis B virus infection in humans.

Authors:  S A Whalley; J M Murray; D Brown; G J Webster; V C Emery; G M Dusheiko; A S Perelson
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

View more
  3 in total

Review 1.  New perspective on the natural course of chronic HBV infection.

Authors:  Yong-Yuan Zhang; Ke-Qin Hu; Zhongping Duan
Journal:  Front Med       Date:  2014-05-29       Impact factor: 4.592

2.  Improving hepatitis B vaccine efficacy in end-stage renal diseases patients and role of adjuvants.

Authors:  Mohammad Hossein Somi; Babak Hajipour
Journal:  ISRN Gastroenterol       Date:  2012-09-18

3.  Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure.

Authors:  Zhihui Xu; Xiaoqiang Ren; Yan Liu; Xiaodong Li; Siyu Bai; Yanwei Zhong; Lin Wang; Panyong Mao; Huifen Wang; Shaojie Xin; Vincent Wai-Sun Wong; Henry Lik-Yuen Chan; Fabien Zoulim; Dongping Xu
Journal:  J Gastroenterol       Date:  2010-09-17       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.